Teva Pharmaceutical Industries (TEVA) Short-term Investments (2009 - 2011)
Teva Pharmaceutical Industries' (TEVA) quarterly Short-term Investments came in at $38.0 million in Q3 2011, up 80.95% YoY from $21.0 million in Q3 2010, and up 111.11% on a QoQ basis from $18.0 million in Q2 2011.
Teva Pharmaceutical Industries (TEVA) Short-term Investments (2009 - 2011) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 3 years of Short-term Investments data on file, last reported at $38.0 million in Q3 2011.
- Quarterly Short-term Investments rose 80.95% year-over-year to $38.0 million in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $38.0 million (up 80.95% YoY) and the FY2010 annual result came in at $36.0 million, down 85.77% from the prior year.
- Short-term Investments improved to $38.0 million in Q3 2011, from $18.0 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $337.0 million in Q1 2010 to a low of $18.0 million in Q2 2011.
- A 3-year average of $93.3 million and a median of $38.0 million in 2011 frame the typical range for Short-term Investments.
- Annual changes were most pronounced in 2010 — Short-term Investments soared 574.0% — and 2011, when it tumbled 91.99%.
- Tracing TEVA's Short-term Investments over 3 years: stood at $253.0 million in 2009, then sank by 85.77% to $36.0 million in 2010, then rose by 5.56% to $38.0 million in 2011.
- The last three Short-term Investments figures came in at $38.0 million (Q3 2011), $18.0 million (Q2 2011), and $27.0 million (Q1 2011), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 38.00 Mn |
| Jun 30, 2011 | 18.00 Mn |
| Mar 31, 2011 | 27.00 Mn |
| Dec 31, 2010 | 36.00 Mn |
| Sep 30, 2010 | 21.00 Mn |
| Jun 30, 2010 | 24.00 Mn |
| Mar 31, 2010 | 337.00 Mn |
| Dec 31, 2009 | 253.00 Mn |
| Sep 30, 2009 | 180.00 Mn |
| Jun 30, 2009 | 42.00 Mn |
| Mar 31, 2009 | 50.00 Mn |